Woldańska-Okońska Marta, Czernicki Jan
Wydziału Fizjoterapii Uniwersytetu Medycznego w łodzi.
Wiad Lek. 2004;57(1-2):44-50.
The anonymous questionnaires which had been filled in by patients were analysed after the end of the magnetostimulation applied with Viofor JPS. The applicator in form of a mattress with maximum induction 45 microT was used. In the analysed group of 1742 patients, 5% of patients suffered from rheumatoid arthritis, 16% from central nervous system illnesses, 9% from injuries, 1.5% from allergies, 2% from infections, 5.4% from vessel illnesses, 1% from skin illnesses. 0.5% of the patients used monotherapy. 8% suffered from radicular symptoms, 30.7% from pseudoradicular symptoms, 17.4% from arthrosis, and 3.4% patients suffered from migraines and headaches. The complete abatement of complaints or the improvement was noted in 95.5% of patients, no improvement in 4.3% and 0.2% of patients became worse--82% of deteriorated patients were the ones that suffered from infections. The strongest analgesic action and the most frequent abatement were noted in patients after injuries and patients with headaches.
在用Viofor JPS进行磁刺激结束后,对患者填写的匿名问卷进行了分析。使用的是感应强度最大为45微特斯拉的床垫式施疗器。在分析的1742名患者中,5%患有类风湿性关节炎,16%患有中枢神经系统疾病,9%患有损伤,1.5%患有过敏,2%患有感染,5.4%患有血管疾病,1%患有皮肤疾病。0.5%的患者采用单一疗法。8%有神经根症状,30.7%有假性神经根症状,17.4%有关节病,3.4%的患者患有偏头痛和头痛。95.5%的患者症状完全缓解或有所改善,4.3%没有改善,0.2%的患者病情恶化——82%病情恶化的患者是患有感染的患者。受伤患者和头痛患者的镇痛作用最强,症状缓解最为常见。